(translations.not_avaliable)
Specifications
Manufacturer: Roche Pharmaceuticals (F. Hoffmann-La Roche Ltd.)
Active ingredient:
Shelf life: 2-3 years (depending on country and production conditions) The exact expiration date is indicated on the packaging and must be strictly observed
Current price
$212
Place an order
Want to find several options? Our manager will clarify all the details of your order and choose a convenient delivery option
Delivery and self-delivery
Storage conditions
- Store at 2°C to 8°C (in the refrigerator)
- Do not freeze
- Protect from light
- Store in original packaging
- Keep out of reach of children
Rocaltrol for Injection contains calcitriol, the active form of vitamin D₃. It is used to manage conditions involving disrupted calcium and phosphorus metabolism.
Indications for Use:
- Hypocalcemia:
- In patients undergoing chronic hemodialysis.
- Secondary Hyperparathyroidism and Metabolic Bone Disorders:
- Associated with chronic renal failure.
Contraindications:
- Hypercalcemia.
- Known hypersensitivity to calcitriol, vitamin D, or its analogs.
- Signs of vitamin D overdose.
Side Effects:
- Metabolic System:
- Hypercalcemia, hyperphosphatemia.
- Gastrointestinal System:
- Nausea, vomiting, constipation.
- Central Nervous System:
- Weakness, headache.
- Allergic Reactions:
- Skin rash, pruritus (itching).
Special Instructions:
- Monitoring:
- Regular monitoring of serum calcium and phosphorus levels is essential during treatment.
- Dietary Considerations:
- Adhere to a diet with controlled calcium intake to prevent hypercalcemia.
- Drug Interactions:
- Concomitant use with magnesium-containing drugs (e.g., antacids) may lead to hypermagnesemia. Exercise caution when combining such therapies.
- Consultation Required:
- Before using Rocaltrol for Injection, consult a healthcare provider to evaluate the appropriateness of treatment and determine the optimal dosage. Self-medication may lead to serious consequences.
Solution for injection: 1 ml (1.0 mcg calcitriol) in an ampoule
- Also available in capsule form (e.g., 0.25 mcg and 0.5 mcg)
In this package: injectable form for intravenous or intramuscular administration
